Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: A randomized prospective study

Transplant International

Volumn 19, Issue 6, 2006, Pages 478-484

  Park, Jae Berm ^a   Kim, Sung Joo ^a   Oh, Ha Young ^a   Han, Young Seok ^a   Kim, Doo Jin ^a   Park, Jin Wan ^a   Kwon, Choon Hyuck ^a   Joh, Jae Won ^a   Lee, Suk Koo ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Cyclosporine; Kidney transplantation; Steroid withdrawal; Tacrolimus

Indexed keywords

CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; SURVIVAL RATE;

ADULT; AGED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEROIDS; TACROLIMUS;

EID: 33646681019     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00303.x     Document Type: Conference Paper

References (33)

1. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome Transplantation 1994 58 443
2. Ratcliffe PJ Dudley CR Higgins RM Firth JD Smith B Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression Lancet 1996 348 643
3. Shapiro R Jordan ML Scantlebury VP et al. A prospective randomized trial of FK506-based immunosuppression after renal transplantation Transplantation 1995 59 485
4. Boots JM Christiaans MH Van Duijnhoven EM Van Suylen RJ Van Hooff JP. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study Transplantation 2002 74 1703
5. Hricik DE Lautman J Bartucci MR Moir EJ Mayes JT Schulak JA. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients Transplantation 1992 53 1232
6. Hricik DE Bartucci MR Mayes JT Schulak JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients Transplantation 1992 54 868
7. Hricik DE Bartucci MR Moir EJ Mayes JT Schulak JA. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients Transplantation 1991 51 374
8. Kasiske BL Chakkera HA Louis TA Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation J Am Soc Nephrol 2000 11 1910
9. Grinyo J Groth C Pichlmayr R et al. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group Lancet 1995 345 1321
10. Halloran P Mathew T Tomlanovich S Groth C Hooftman L Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups Transplantation 1997 63 39
11. Vincenti F Monaco A Grinyo J Kinkhabwala M Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil Am J Transplant 2003 3 306
12. Khwaja K Asolati M Harmon J et al. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients Am J Transplant 2004 4 980
13. Rama I Cruzado JM Gil-Vernet S et al. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results Transplantation 2005 80 164
14. Mayer AD Dmitrewski J Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group Transplantation 1997 64 436
15. Vincenti F Jensik SC Filo RS Miller J Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years Transplantation 2002 73 775
16. Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study Lancet 2002 359 741
17. Ahsan N Johnson C Gonwa T et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years Transplantation 2001 72 245
18. Abramowicz D Vanrenterghem Y Squifflet JP et al. Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial Clin Transplant 2005 19 475
19. Woodle ES Vincenti F Lorber MI et al. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus Am J Transplant 2005 5 157
20. Heisel O Heisel R Balshaw R Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis Am J Transplant 2004 4 583
21. Walczak DA Calvert D Jarzembowski TM et al. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients Clin Transplant 2005 19 527
22. Vanrenterghem Y van Hooff JP Squifflet JP et al. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial Am J Transplant 2005 5 87
23. Hricik DE Whalen CC Lautman J et al. Withdrawal of steroids after renal transplantation - clinical predictors of outcome Transplantation 1992 53 41
24. Grinyo JM Gil-Vernet S Seron D et al. Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients Transplantation 1997 63 1688
25. Siddiqi N McBride MA Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Kidney Int 2004 65 1906
26. Hricik DE Seliga RM Fleming-Brooks S Bartucci MR Schulak JA. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients Clin Transplant 1995 9 419
27. Zucker K Rosen A Tsaroucha A et al. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy Transplant Proc 1997 29 334
28. van Gelder T Klupp J Barten MJ Christians U Morris RE. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid Ther Drug Monit 2001 23 119
29. Hohage H Zeh M Heck M Gerhardt UW Welling U Suwelack BM. Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function Transplant Proc 2005 37 1748
30. Matas AJ. Risk factors for chronic rejection - a clinical perspective Transpl Immunol 1998 6 1
31. Ahsan N Hricik D Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Steroid Withdrawal Study Group Transplantation 1999 68 1865
32. Pascual J Quereda C Zamora J Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials Transplantation 2004 78 1548
33. Leggat Jr. JE Ojo AO Leichtman AB et al. Long-term renal allograft survival: prognostic implication of the timing of acute rejection episodes Transplantation 1997 63 1268